Propane, 1,2-dichloro-

RTECS #
TX9625000
CAS #
78-87-5
See: NMAM or OSHA Methods
Updated
March 2019
Molecular Weight
112.99
Molecular Formula
C3H6Cl2
Synonyms
1,2-Dichloropropane
1,2-Dichloropropane (OSHA)
alpha,beta-Dichloropropane
alpha,beta-Propylene dichloride
Bichlorure de propylene (French)
Dwuchloropropan (Polish)
ENT 15,406
NCI-C55141
Propylene chloride
Propylene dichloride (ACGIH:OSHA)
RCRA waste number U083

Skin and Eye Irritation and References

Route/OrganismDoseEffectReference
eye /rabbit 500 mg mildAIHAAP 30,470,1969
eye /rabbit 0.05 mLHPV170 -,-,2004
skin /rabbit 0.5 mL mildHPV170 -,-,2004

Mutation Data and Reference

System TestRoute/Organism/TissueDoseReference
Cytogenetic Analysisovary/hamster660 mg/LNTPTR* NTP-TR-263,1986
Cytogenetic Analysisovary/hamster1370000 µg/L/8H (-enzymatic activation step)HPV170 -,-,2004
DNA Damageliver/human5 mmol/L/1HTOLED5 272,60,2017
DNA Damageliver/human1 mmol/L/4HTOLED5 272,60,2017
DNA Damageother cell types/human3 mmol/L/4HTOLED5 272,60,2017
DNA Damageother cell types/human5 mmol/L/1HTOLED5 272,60,2017
DNA Damageinhalation/mouse200 ppm/6H/2D- intermittentTOLED5 272,60,2017
mutation in microorganisms/Salmonella typhimurium300 gm/L/48HMUTAEX 32,455,2017
mutation in microorganisms/Salmonella typhimurium100 µg/plate (+enzymatic activation step)ENMUDM 5(Suppl 1),3,1983
mutation in microorganismslymphocyte/mouse11600 µg/L (+enzymatic activation step)SCIEAS 236,933,1987
sister chromatid exchangeovary/hamster113 mg/LEMMUEG 10(Suppl 10),1,1987
sister chromatid exchangelung/hamster3300 µmol/LENMUDM 9,401,1987
sister chromatid exchangeovary/hamster376000 µg/L/24H (+/-enzymatic activation step)HPV170 -,-,2004

Reproductive Effects Data and References

Route/OrganismDoseEffectReference
oral/rat 1250 mg/kg (6-15D pregnant)Reproductive: Other effects on femaleFAATDF 28,18,1995
oral/rabbit 1950 mg/kg (7-19D pregnant)Reproductive: Other effects on femaleFAATDF 28,18,1995
oral/rat 1250 mg/kg (6-15D pregnant)Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus)HPV170 -,-,2004
oral/rabbit 1950 mg/kg (7-19D pregnant)Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus)HPV170 -,-,2004

Tumorigenic Data and References

Route/OrganismDoseEffectReference
oral/mouse lowest published toxic dose: 130 gm/kg/2Y- intermittentTumorigenic: Carcinogenic by RTECS criteria

Skin and Appendages: Tumors
NTPTR* NTP-TR-263,1986
oral/mouse lowest published toxic dose: 64375 mg/kg/103W- intermittentTumorigenic: Carcinogenic by RTECS criteria

Liver: Tumors
NTIS** PB87-114443/AS
oral/mouse lowest published toxic dose: 64375 mg/kg/103W- intermittentTumorigenic: Neoplastic by RTECS criteria

Liver: Tumors

Tumorigenic: Increased incidence of tumors in susceptible strains
HPV170 -,-,2004
oral/rat lowest published toxic dose: 128750 mg/kg/103W- intermittentTumorigenic: Equivocal tumorigenic agent by RTECS criteria

Skin and Appendages: Tumors

Tumorigenic: Increased incidence of tumors in susceptible strains
HPV170 -,-,2004
oral/rat lowest published toxic dose: 128750 mg/kg/103W- intermittentTumorigenic: Carcinogenic by RTECS criteria

Skin and Appendages: Tumors
NTIS** PB87-114443/AS

Acute Toxicity Data and References

Route/OrganismDoseEffectReference
In Vitro/Human, liver Inhibitor Concentration Low: 1 mmol/L/4HIn Vitro Toxicity Studies: Other assaysTOLED5 272,60,2017
inhalation/guinea pig lethal concentration (50 percent kill): >2200 ppm/7HLiver: Fatty liver degenerationHPV170 -,-,2004
inhalation/mouse Lowest published lethal concentration: 1000 ppm/2HJIHTAB 28,1,1946
inhalation/mouse lowest published toxic concentration: 10500 mg/m3/2HBehavioral: General anestheticVCVGH* -,307,1990
inhalation/mouse lethal concentration (50 percent kill): 2256 mg/m3/10HHPV170 -,-,2004
inhalation/rat lethal concentration (50 percent kill): 300 ppm/8HVCVGH* -,395,1990
inhalation/rat lethal concentration (50 percent kill): 14000 mg/m3/8HHPV170 -,-,2004
inhalation/rat Lowest published lethal concentration: 10340 mg/m3/7HLiver: Hepatitis (hepatocellular necrosis), zonal

Liver: Fatty liver degeneration
HPV170 -,-,2004
inhalation/rat lethal concentration (50 percent kill): 2000 ppm/4HHPV170 -,-,2004
inhalation/rat lethal concentration (50 percent kill): >2200 ppm/7HLiver: Fatty liver degenerationHPV170 -,-,2004
inhalation/rat lowest published toxic concentration: 10500 mg/m3Lung, Thorax, or Respiration: CoughVCVGH* -,395,1990
intraperitoneal/mouse lowest published lethal dose: 316 mg/kgHPV170 -,-,2004
intraperitoneal/rat lethal dose (50 percent kill): 230 mg/kgHPV170 -,-,2004
oral/Dog lowest published lethal dose: 5 gm/kgBehavioral: Sleep

Liver: Other changes
AJHYA2 16,325,1932
oral/guinea pig lethal dose (50 percent kill): 2000 mg/kgHPV170 -,-,2004
oral/mouse lethal dose (50 percent kill): 860 mg/kgHPV170 -,-,2004
oral/rat lethal dose (50 percent kill): 2890 mg/kgBehavioral: Somnolence (general depressed activity)HPV170 -,-,2004
oral/rat lethal dose (50 percent kill): 1900 mg/kgVCVGH* -,395,1990
skin/rabbit lethal dose (50 percent kill): 8750 mg/kgVCVGH* -,395,1990
skin/rabbit lethal dose (50 percent kill): 8750 µL/kgUCDS** 7/28/1966
skin/rat lethal dose (50 percent kill): >2000 mg/kgHPV170 -,-,2004
unreported route/mouse lethal dose (50 percent kill): 960 mg/kgGastrointestinal: Ulceration or bleeding from stomach

Gastrointestinal: Ulceration or bleeding from small intestine
ESKGA2 28,P31,1982

Other Multiple Dose Data and References

Route/OrganismDoseEffectReference
inhalation/Dog lowest published toxic concentration: 1000 ppm/7H/26W- intermittentLiver: Fatty liver degeneration

Kidney, Ureter, and Bladder: Changes in tubules (including acute renal failure, acute tubular necrosis)

Endocrine: Other changes
JIHTAB 28(1),1,1946
inhalation/Dog lowest published toxic concentration: 4400 mg/m3/27D- intermittentLiver: Fatty liver degeneration

Kidney, Ureter, and Bladder: Changes in tubules (including acute renal failure, acute tubular necrosis)

Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
HPV170 -,-,2004
inhalation/guinea pig lowest published toxic concentration: 10400 mg/m3/5D- intermittentLiver: Hepatitis (hepatocellular necrosis), zonal

Liver: Fatty liver degeneration

Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
HPV170 -,-,2004
inhalation/guinea pig lowest published toxic concentration: 1500 ppm/7H/8W- intermittentLiver: Fatty liver degeneration

Endocrine: Other changes

Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
JIHTAB 28(1),1,1946
inhalation/mouse lowest published toxic concentration: 400 ppm/7H/120D- intermittentRelated to Chronic Data: Death in the "MULTIPLE DOSE" data type fieldVCVGH* -,395,1990
inhalation/mouse lowest published toxic concentration: 400 ppm/7H/7W- intermittentLiver: Fatty liver degeneration

Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
JIHTAB 30(3),189,1948
inhalation/rabbit lowest published toxic concentration: 150 ppm/13W- intermittentBlood: Changes in erythrocyte (RBC) countHPV170 -,-,2004
inhalation/rabbit lowest published toxic concentration: 10400 mg/m3/2D- intermittentLiver: Fatty liver degeneration

Blood: Changes in spleen

Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
HPV170 -,-,2004
inhalation/rat lowest published toxic concentration: 50 ppm/13W- intermittentBrain and Coverings: Changes in brain weight

Cardiac: Changes in heart weight

Nutritional and Gross Metabolic: Weight loss or decreased weight gain
HPV170 -,-,2004
inhalation/rat lowest published toxic concentration: 10 mg/m3/30D- continuousBiochemical: Enzyme inhibition, induction, or change in blood or tissue levels: PhosphatasesVCVGH* -,395,1990
inhalation/rat lowest published toxic concentration: 10 mg/m3/60D- continuousBiochemical: Enzyme inhibition, induction, or change in blood or tissue levels: PhosphatasesVCVGH* -,395,1990
inhalation/rat lowest published toxic concentration: 10 mg/m3/90D- continuousLung, Thorax, or Respiration: Acute pulmonary edema

Lung, Thorax, or Respiration: Other changes

Blood: Hemorrhage
VCVGH* -,395,1990
inhalation/rat lowest published toxic concentration: 9 mg/m3/24H/94D- continuousBrain and Coverings: Recordings from specific areas of CNS

Lung, Thorax, or Respiration: Other changes

Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
GISAAA 42(8),50,1977
inhalation/rat lowest published toxic concentration: 10 mg/m3/24H/60D- intermittentLiver: Other changes

Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Phosphatases

Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Dehydrogenases
GISAAA 47(10),21,1982
inhalation/rat lowest published toxic concentration: 1000 ppm/7H/20W- intermittentLiver: Fatty liver degeneration

Blood: Changes in spleen

Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
JIHTAB 28(1),1,1946
intraperitoneal/rat lowest published toxic dose: 2500 mg/kg/5D- intermittentLiver: Other changes

Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other transferases
ARTODN 63,445,1989
intraperitoneal/rat lowest published toxic dose: 1400 mg/kg/4W- intermittentLiver: Other changes

Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other transferases
ARTODN 63,445,1989
intraperitoneal/rat lowest published toxic dose: 10000 mg/kg/4W- intermittentLiver: Other changes

Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Multiple enzyme effects

Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
HPV170 -,-,2004
oral/mouse lowest published toxic dose: 1750 mg/kg/14D- intermittentKidney, Ureter, and Bladder: Other changesHPV170 -,-,2004
oral/mouse lowest published toxic dose: 7000 mg/kg/14D- intermittentKidney, Ureter, and Bladder: Other changes

Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
HPV170 -,-,2004
oral/mouse lowest published toxic dose: 64375 mg/kg/103W- intermittentLiver: Hepatitis (hepatocellular necrosis), zonalHPV170 -,-,2004
oral/mouse lowest published toxic dose: 128750 mg/kg/103W- intermittentLiver: Hepatitis (hepatocellular necrosis), zonal

Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
HPV170 -,-,2004
oral/mouse lowest published toxic dose: 32500 mg/kg/13W- intermittentRelated to Chronic Data: Death in the "MULTIPLE DOSE" data type fieldNTPTR* NTP-TR-263,1986
oral/rat lowest published toxic dose: 435 mg/kg/30D- intermittentBlood: Changes in serum composition (e.g. TP, bilirubin, cholesterol)

Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Transaminases

Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other enzymes
RCTOE4 104,93,1988
oral/rat lowest published toxic dose: 28 gm/kg/14D- intermittentKidney, Ureter, and Bladder: Other changes

Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
NTPTR* NTP-TR-263,1986
oral/rat lowest published toxic dose: 109 mg/kg/26W- intermittentGastrointestinal: Changes in structure or function of exocrine pancreas

Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other hydrolases
GISAAA 39(1),94,1974
oral/rat lowest published toxic dose: 16250 mg/kg/13W- intermittentLiver: Changes in liver weight

Endocrine: Changes in spleen weight

Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Transaminases
FAATDF 12,713,1989
oral/rat lowest published toxic dose: 32500 mg/kg/13W- intermittentNutritional and Gross Metabolic: Weight loss or decreased weight gain

Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
HPV170 -,-,2004
oral/rat lowest published toxic dose: 65000 mg/kg/13W- intermittentLiver: Fatty liver degeneration

Nutritional and Gross Metabolic: Weight loss or decreased weight gain

Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
HPV170 -,-,2004
oral/rat lowest published toxic dose: 64375 mg/kg/103W- intermittentNutritional and Gross Metabolic: Weight loss or decreased weight gainHPV170 -,-,2004
oral/rat lowest published toxic dose: 128750 mg/kg/103W- intermittentLiver: Hepatitis (hepatocellular necrosis), zonal

Nutritional and Gross Metabolic: Weight loss or decreased weight gain

Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
HPV170 -,-,2004
oral/rat lowest published toxic dose: 5000 mg/kg/5D- intermittentBlood: Changes in serum composition (e.g. TP, bilirubin, cholesterol)

Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Multiple enzyme effects
HPV170 -,-,2004

Reviews

OrganizationStandardReference
American Conference of Governmental Industrial Hygienists (ACGIH)Threshold Limit Value-time-weighted average 10 ppm (sen)DTLVS* TLV/BEI,2013
American Conference of Governmental Industrial Hygienists (ACGIH)Threshold Limit Value-Not classifiable as a human carcinogenDTLVS* TLV/BEI,2013
International Agency for Research on Cancer (IARC)Cancer Review:Animal Limited EvidenceIMEMDT 41,131,1986
International Agency for Research on Cancer (IARC)Cancer Review:Animal Limited EvidenceIMEMDT 71,1393,1999
International Agency for Research on Cancer (IARC)Cancer Review:Human No Adequate DataIMEMDT 41,131,1986
International Agency for Research on Cancer (IARC)Cancer Review:Human No Adequate DataIMEMDT 71,1393,1999
International Agency for Research on Cancer (IARC)Cancer Review:Group 3IMEMDT 71,1393,1999
TOXICOLOGY REVIEWPAREAQ 4,1,1952
TOXICOLOGY REVIEWMUREAV 543,201,2003
TOXICOLOGY REVIEWMUREAV 567,347,2004
TOXICOLOGY REVIEWMUREAV 584,1,2005
TOXICOLOGY REVIEWHUTOX* -,561,1996
TOXICOLOGY REVIEWHUTOX* -,577,1996
TOXICOLOGY REVIEWFCTOD7 47,1287,2009
TOXICOLOGY REVIEWMUTAEX 23,271,2008
TOXICOLOGY REVIEWMUREAV 769,34,2014
TOXICOLOGY REVIEWMUREAV 802,1,2016
TOXICOLOGY REVIEWREPTED 71,71,2017
TOXICOLOGY REVIEWRTOPDW 55,43,2009
TOXICOLOGY REVIEWRTOPDW 59,364,2011

Standards and Regulations

OrganizationStandardReference
Mine Safety and Health Administration (MSHA) STANDARD-airtime-weighted average 75 ppm (350 mg/m3)DTLVS* 3,218,1971
Occupational Exposure Limit IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN check ACGIH TLV;
Occupational Exposure Limit IN SINGAPORE, VIETNAM check ACGIH TLV
Occupational Exposure Limit-AUSTRALIAtime-weighted average 75 ppm (347 mg/m3), short term exposure limit 110 ppm (508 mg/m3), JUL2008
Occupational Exposure Limit-AUSTRIAMAK-TMW 75 ppm (350 mg/m3);KZW 375 ppm (1750 mg/m3), 2007
Occupational Exposure Limit-BELGIUMtime-weighted average 75 ppm (352 mg/m3), short term exposure limit 110 ppm(515 mg/m3), MAR2002
Occupational Exposure Limit-DENMARKtime-weighted average 75 ppm (350 mg/m3), MAY2011
Occupational Exposure Limit-FINLANDtime-weighted average 10 ppm (46 mg/m3), short term exposure limit 20 ppm (92 mg/m3), NOV2011
Occupational Exposure Limit-FRANCEVME 75 ppm (350 mg/m3), FEB2006
Occupational Exposure Limit-HUNGARYtime-weighted average 50 mg/m3, short term exposure limit 50 mg/m3, SEP2000
Occupational Exposure Limit-ICELANDtime-weighted average 75 ppm (350 mg/m3), NOV2011
Occupational Exposure Limit-KOREAtime-weighted average 75 ppm (350 mg/m3), short term exposure limit 110 ppm (510 mg/m3), 2006
Occupational Exposure Limit-MEXICOtime-weighted average 75 ppm (350 mg/m3);short term exposure limit 110 ppm (510 mg/m3), 2004
Occupational Exposure Limit-NEW ZEALANDtime-weighted average 75 ppm (347 mg/m3), short term exposure limit 110 ppm (508 mg/m3), JAN2002
Occupational Exposure Limit-NORWAYtime-weighted average 40 ppm (185 mg/m3), JAN1999
Occupational Exposure Limit-PERUtime-weighted average 75 ppm (347 mg/m3); short term exposure limit 110 ppm (508 mg/m3), JUL2005
Occupational Exposure Limit-POLANDMAC(time-weighted average) 50 mg/m3, MAC(short term exposure limit) 400 mg/m3, JAN1999
Occupational Exposure Limit-RUSSIAshort term exposure limit 10 mg/m3, JUN2003
Occupational Exposure Limit-SWITZERLANDMAK-week 75 ppm (350 mg/m3), JAN2011
Occupational Exposure Limit-THE NETHERLANDSMAC-TGG 350 mg/m3, 2003
Occupational Exposure Limit-THE PHILIPPINEStime-weighted average 75 ppm (350 mg/m3), JAN1993
Occupational Exposure Limit-TURKEYtime-weighted average 74 ppm (350 mg/m3), JAN1993
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Construction)8H time-weighted average 75 ppm (350 mg/m3)CFRGBR 29,1926.55,1994
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Federal Contractors)8H time-weighted average 75 ppm (350 mg/m3)CFRGBR 41,50-204.50,1994
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (General Industry)8H time-weighted average 75 ppm (350 mg/m3)CFRGBR 29,1910.1000,1994
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Shipyards)8H time-weighted average 75 ppm (350 mg/m3)CFRGBR 29,1915.1000,1993

NIOSH Documentation and Surveillance

OrganizationStandardReference
National Institute for Occupational Safety and Health (NIOSH) Recommended Exposure Level TO PROPYLENE DICHLORIDE-airCarcinogen lowest feasible conc.NIOSH* DHHS #92-100,1992
National Occupational Exposure Survey 1983Hazard Code 24390; Number of Industries 6; Total Number of Facilities 116; Number of Occupations 15; Total Number of Employees Exposed 2944; Total Number of Female Employees Exposed 1022
National Occupational Hazard Survey 1974Hazard Code 24390; Number of Industries 13; Total Number of Facilities 653; Number of Occupations 15; Total Number of Employees Exposed 9601

Status in Federal Agencies

OrganizationReference
ATSDR TOXICOLOGY PROFILE (NTIS** PB/90/182122/AS)
EPA GENETOX PROGRAM 1988, Positive: Histidine reversion-Ames test
EPA TSCA 8(a) PRELIMINARY ASSESSMENT INFORMATION, FINAL RULEFEREAC 47,26992,82
EPA TSCA Section 8(b) CHEMICAL INVENTORY
EPA TSCA Section 8(d) unpublished health/safety studies
EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001
NCI Carcinogenesis Studies (gavage);equivocal evidence:mouse,rat
NIOSH Analytical Method, 1994: Propylene dichloride, 1013
NTP Carcinogenesis Studies (gavage);some evidence:mouse NTPTR* NTP-TR-263,1986
On EPA IRIS database
Page last reviewed: November 16, 2018